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Around 300 million people worldwide are affected with 
diabetes, and this number is forecast to increase to over 
550 million by the year 2030.[1] Of those affected, 80% 
live in low- and middle-income countries (LMICs).[1] In 
South Africa (SA), the prevalence of type 2 diabetes rose 
from 5.5% in adults in 2000 to 9.0% in 2009. Currently approximately 2 
million South Africans live with type 2 diabetes, with a projected 115 000 
new cases per year.[1] It is of concern that about 55% of people with 
diabetes are likely to suffer from diabetic retinopathy.[2] Diabetes is the 
third leading cause of blindness in SA, with retinopathy and cataracts[2] 
accounting for 8  000 new cases of vision impairment every year. In a 
2010 survey in Cape Town, diabetic retinopathy was responsible for 8% 
of blindness and 11% of severe visual impairment.[3] In LMICs, including 
SA, diabetic blindness creates a poverty cycle that disables breadwinners 
and burdens caregivers. The fact that timely treatment of diabetic 
retinopathy can reduce the risk of visual impairment by 90%[2] implies 
a need for screening and early detection. The Ophthalmology Society 
of South Africa has recommended a strategy for diabetic retinopathy 
screening using a validated grading system, an internet-based database 
and tracking system, and a patient-held ‘scorecard’.[4]
In 2007, a pilot study in Cape Town evaluated the impact of mobile 
fundus photography to screen for diabetic retinopathy.[5] Following the 
screening, an ophthalmic specialist reviewed the photographs and if 
necessary referred the patient. This proved effective and allowed a single 
technician to screen about 10 000 patients annually, suggesting that scale-
up is feasible.
Despite this, a systematic review revealed a lack of information on 
the cost-effectiveness of using mobile fundus cameras as a screening 
method.[6] In response, PRICELESS-SA and collaborators measured 
the prevalence of type 2 diabetes and its associated complications in SA 
based on 2009 data.[7] Using these estimates together with data from the 
pilot project, modelling was performed on the cost and consequences of 
using a mobile fundus camera in a primary care setting.[7] Screening via 
camera alone cost an average of ZAR189 per person, including follow-
up operation procedures, ranging from a lower limit of ZAR10 500 to 
an upper limit of ZAR23 327 per case of blindness averted.
Relevance to policy
Advocacy for preventive screening of diabetic retinopathy intersects 
early stages in the development of SA’s National Health Insurance 
(NHI). As the NHI will not cover diagnostic procedures outside 
its approved guidelines and protocols, it is essential that screening 
for diabetic retinopathy be considered for scale-up nationally and 
therefore for inclusion in these guidelines. At present, screening 
for retinopathy at primary care level is almost non-existent, despite 
current guidelines recommending annual screening.[6,8] In addition, 
ophthalmic referral and treatment in the form of laser therapy and 
operations are reserved for the tertiary care sector.[9]
Difficulty of access to screening and treatment of diabetic blindness 
is exacerbated by the 55% of diabetic patients who remain undiagnosed. 
The government provides support through monthly disability grants 
for the blind, totalling ZAR12 120 per year per blind person.[10] In 
comparison, the cost-effectiveness study showed that the ZAR10 500 
per blindness case averted is less than the expense of one year of 
a disability grant. Prevention of blindness would also extend the 
number of working years for every diabetic patient. The use of mobile 
fundus cameras has huge savings potential compared with the current 
situation of diabetes treatment and disability coverage.
International comparisons
Canadian researchers found fundus cameras to be cost-effective 
compared with their alternative specialist-based programme. Camera 
screening saved 67 sight-years at US$3 900 per sight-year, while the 
alternative programme saved only 56 sight-years at US$9 800 per sight-
year.[11] Although the SA pilot project was performed in an urban setting, 
similar projects in rural communities in Australia[12] and France[13] 
proved to be effective. US researchers[14] have also built a prototype 
mobile fundus camera that will cut costs significantly and potentially 
make screening for diabetic blindness even more cost-effective. Smart-
phone technology that might allow screening for diabetic retinopathy 
using mobile phones is now being tested elsewhere in Africa.[15]
International examples show that camera screening for diabetic vision 
impairment is successful at a national scale. Such systematic screening 
OPINION
Preventing diabetic blindness: A priority for  
South Africa
K J Hofman, C Cook, N Levitt
Karen Hofman is a medical graduate of the University of the Wit watersrand, Johannesburg, South Africa, and a paediatrician. She is Director of 
PRICELESS SA (Priority Cost Eective Lessons for Systems Strengthening), focused on ‘best buys’ in public health and based at the Medical Research 
Council/Wits Rural Public Health Unit (Agincourt) in the School of Public Health, Faculty of Health Sciences, University of the Witwatersrand. 
Colin Cook is a graduate of the University of Cape Town, South Africa, and Morris Mauberger Professor of Ophthalmology in the Department of 
Surgery, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town. Dinky (Naomi) Levitt, also a UCT graduate, 
is Head of the Division of Diabetes and Endocrinology in the Department of Medicine at UCT and Groote Schuur Hospital and Director of the 
Chronic Diseases Initiative for Africa, Cape Town.
Corresponding author: K J Hofman (karen.hofman@wits.ac.za)
The prevalence of diabetes in South Africa is increasing rapidly, and diabetes is a significant cause of blindness. Diabetic complications can 
induce a cycle of poverty for affected families. Early detection of retinopathy and appropriate management can prevent blindness. Screening for 
retinopathy using a mobile retinal camera is highly cost-effective, with costs of screening and follow-up treatment being less than the expense 
of one year of a disability grant. Such a programme is a prime example of a ‘best buy’ that should be part of the national diabetes care package.
S Afr Med J 2014;104(10):661-662. DOI:10.7196/SAMJ.8580
AT MEDICLINIC, OUR DECISIONS ARE CALCULATED. OUR ACTIONS ARE CONSIDERED. 
WE SHARE EXPERT KNOWLEDGE AND COLLECTIVE SKILL FROM OUR HOSPITALS 
AROUND THE WORLD. WITH THIS KNOWLEDGE, WE CAN CONTRIBUTE TO A FUTURE 
HEALTH SYSTEM IN WHICH VERIFIABLE, COST-EFFECTIVE QUALITY HEALTHCARE 
WILL NOT BE COMPROMISED.
WE’RE OBSESSED
WITH THE FUTURE.
SOUTH AFRICA • SWITZERLAND • UAE • NAMIBIA
www.mediclinic.co.za








40674 Mclinic SA Medical Journal.indd   1
FORUM
662       October 2014, Vol. 104, No. 10
has been established in Iceland for over 30 years. In 1980, 2.4% of 
Iceland’s population was legally blind, but by 2005 the prevalence 
had dropped to 0.5%.[16] Similarly, Israel’s prevalence of preventable 
blindness dropped by half from 33.8/100 000 in 1999 to 16.6/100 000 in 
2008.[17] These declines can be attributed to the availability of treatment 
and preventive measures and illustrate the importance of implementing 
treatment guidelines for diabetic vision impairment.
In sub-Saharan Africa, countries have utilised other alternatives 
by task-shifting cataract operations from ophthalmologists to non-
physician cataract surgeons (NPCSs). NPCSs in Kenya, Tanzania 
and Ethiopia, for example, performed over 77 000 operations in 
2000 - 2004.[18] Results showed no difference between specialised 
ophthalmologists and NPCSs in respect of the quality of surgeries 
conducted.[19] Although the use of NPCSs is not widely accepted, 
they represent a cost-effective alternative solution. Laser treatment 
for diabetic retinopathy by appropriately trained doctors at secondary 
level and district hospitals would be a feasible solution to deal with 
diabetic retinopathy-related blindness in SA.
‘Best buys’ for policy makers
Under the current economic circumstances, every ZAR must work 
more effectively, efficiently and equitably. In order for the SA 
government to discern a ‘best buy’ among cost-effective options, it 
needs access to valid, reliable and comparable information on costs 
and consequences of policy alternatives. International examples do 
provide useful information, but this must be complemented by local 
context-specific evidence. Prevention interventions offer particularly 
good value, as they produce the largest gain.
Conclusion
The use of mobile fundus cameras to screen for diabetic vision 
impairment is a paradigm of an innovative approach to achieve 
economies of scale to reduce preventable blindness effectively on a 
national level. The use of mobile fundus cameras would interface well 
with the screening strategy recommended by the Ophthalmology 
Society of South Africa. One of the challenges for the evolving NHI 
is how value for money and affordability can be balanced across 
competing priorities. This approach is one example of a ‘best buy’ 
that could potentially be incorporated in a diabetes care package.
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